Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, August 5, 2016
[ Fri, Aug 05th 2016
] - WOPRAI
[ Fri, Aug 05th 2016
] - WOPRAI
[ Fri, Aug 05th 2016
] - WOPRAI
[ Fri, Aug 05th 2016
] - WOPRAI
[ Fri, Aug 05th 2016
] - WOPRAI
[ Fri, Aug 05th 2016
] - WOPRAI
[ Fri, Aug 05th 2016
] - WOPRAI
[ Fri, Aug 05th 2016
] - WOPRAI
[ Fri, Aug 05th 2016
] - WOPRAI
[ Fri, Aug 05th 2016
] - WOPRAI
[ Fri, Aug 05th 2016
] - WOPRAI
[ Fri, Aug 05th 2016
] - WOPRAI
[ Fri, Aug 05th 2016
] - WOPRAI
[ Fri, Aug 05th 2016
] - WOPRAI
[ Fri, Aug 05th 2016
] - WOPRAI
[ Fri, Aug 05th 2016
] - WOPRAI
[ Fri, Aug 05th 2016
] - WOPRAI
[ Fri, Aug 05th 2016
] - WOPRAI
[ Fri, Aug 05th 2016
] - WOPRAI
[ Fri, Aug 05th 2016
] - WOPRAI
[ Fri, Aug 05th 2016
] - WOPRAI
[ Fri, Aug 05th 2016
] - WOPRAI
[ Fri, Aug 05th 2016
] - WOPRAI
[ Fri, Aug 05th 2016
] - WOPRAI
Anupam Rama Maintained (ALNY) at Buy with Increased Target to $83 on, Aug 5th, 2016
Anupam Rama of JP Morgan, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy with Increased Target from $80 to $83 on, Aug 5th, 2016.
Anupam has made no other calls on ALNY in the last 4 months.
There is 1 other peer that has a rating on ALNY. Out of the 1 peers that are also analyzing ALNY, 0 agree with Anupam's Rating of Hold.
This is the rating of the analyst that currently disagrees with Anupam
- Paul Matteis of "Leerink Swann" Maintained at Buy with Decreased Target to $107 on, Tuesday, May 3rd, 2016
Similar Stocks and Investing Articles
[ Tue, May 03rd 2016
] - WOPRAI
[ Fri, Mar 11th 2016
] - WOPRAI
[ Tue, Feb 16th 2016
] - WOPRAI
[ Wed, Jan 20th 2016
] - WOPRAI
[ Tue, Nov 10th 2015
] - WOPRAI
[ Mon, Aug 31st 2015
] - WOPRAI
[ Fri, Aug 07th 2015
] - WOPRAI
[ Fri, Aug 07th 2015
] - WOPRAI
[ Fri, Aug 09th 2013
] - WOPRAI
[ Mon, Jul 16th 2012
] - WOPRAI